Contact Us |  Careers | News | Terms and Conditions
Osmotica

text text text text text
PRODUCTS

We're a global company focused on sophisticated products.

As one of the world's leading osmotic drug delivery companies, Osmotica Pharmaceutical is leveraging its significant resources in R&D and proprietary drug delivery technology to address the growing needs of the global patient population.
Learn more. >>
TECHNOLOGY
We don't just face challenges, we overcome them.
Osmotica has developed a broad portfolio of intellectual property including issued and pending patents and proprietary know-how. We're expanding our osmotic capabilities and actively developing next-generation, non-osmotic technologies.
Learn more. >>
MAKING HEADLINES

October 17, 2013
Osmotica Pharmaceutical Corp. Announces the Appointment of Kenneth Gayron as Vice President and Chief Financial Officer
September 27, 2013
Osmotica Announces the Commercial Launch of Its KHEDEZLA™ (desvenlafaxine) Extended-release Tablets, 50 mg and 100 mg
September 6, 2013
Osmotica Announces the Appointment of Gene Wright, Pharm.D., Ph.D. as VP, Head of Global Clinical Development